STAT Plus: What value? High prices for dozens of cancer drugs aren’t tied to better clinical benefits
As payers increasingly demand good value for medicines, a new analysis found that costs for…
Category: drug pricing
STAT Plus: Pharmalittle: Japan plans fast-track review of Gilead drug for Covid-19; most Americans think Trump whiffed on drug prices
Rise and shine, everyone, another busy and disorienting day is on the way. Although uncertainty…
STAT Plus: California fines more than a dozen drug makers for not providing drug pricing data
Over the past six months, California state authorities fined more than a dozen drug makers…
STAT Plus: Most Americans believe Trump has failed to make progress lowering drug prices
More than one-third of U.S. adults believe that prescription drug prices have increased a lot…
STAT Plus: Vertex’s new cystic fibrosis drug needs to be far cheaper to be cost-effective, analysis finds
A newly approved treatment from Vertex Pharmaceuticals (VRTX) that targets roughly 90% of all cystic…
STAT Plus: Gilead sues U.S., claiming it ‘secretly’ obtained patents on HIV research that led to Truvada
Gilead Sciences (GILD) has accused the U.S. government of breaching several contracts and “secretly” obtaining…
STAT Plus: Despite pricing controversies, pharma’s reputation is improving among patient groups
Even before the pandemic struck and drug makers were seen as potential saviors, the pharmaceutical…
STAT Plus: After a hard-won political fight, this state expanded access to insulin. Can others follow its lead?
On Tuesday, April 14th, Nicole Smith-Holt watched from the top balcony of the Minnesota state…
STAT Plus: Pharmacy reimbursement often lags for generics undergoing price hikes, jeopardizing patient access
Of more than 4,300 instances in which pharmacies saw generic drug prices rise by 50%…
STAT Plus: State legislatures are lapping the federal government on drug pricing — even amid the coronavirus
A version of this article first ran in D.C. Diagnosis, STAT’s weekly newsletter about the…
Brazilian lawmakers propose compulsory licensing for Covid-19 products
As concerns mount over access to Covid-19 medical products, Brazil has become the latest country…
Some drugs being tested as Covid-19 treatments could be very cheap to make
Some existing medicines that may be repurposed to fight Covid-19 could also be manufactured profitably…
STAT Plus: Insurers, drug makers, and patient advocates blast two Trump proposals to drive down drug prices
WASHINGTON — The Trump administration has proposed modest steps this year to promote biosimilar and…
.jpg)
A key ingredient that compound pharmacies need for hydroxychloroquine skyrockets in price
As global demand intensifies for an old malaria drug that some believe can combat Covid-19,…
STAT Plus: Opioid-overdose prescriptions may go unfilled due to the cost
Although naloxone is widely regarded as an effective antidote for reversing opioid overdoses, a new…
Wealthy nations urged to embrace WTO deal and import meds made under compulsory licenses
In the latest effort to widen access to Covid-19 medical products, three dozen countries are…
STAT Plus: Lilly lowers most insulin costs to $35 a month in response to Covid-19
In response to the financial hit many people are taking due to the coronavirus pandemic,…
STAT Plus: Large employers could have saved money if more biosimilars had been prescribed
If some of the largest U.S. employers had used biosimilar versions of a pair of…
STAT Plus: Lawmakers’ coronavirus response means delays for drug pricing legislation
WASHINGTON — Before the coronavirus pandemic became Congress’ sole focus, late May was widely viewed…
Pressure mounts to widen access to medical products that may combat Covid-19
As more companies gear up to fight the spread of the novel coronavirus, a growing…
A Canadian bill would make it easier to issue compulsory licenses for Covid-19 products
In response to the pandemic, Canadian lawmakers have passed a bill that would speed the…
Under intense criticism, Gilead forsakes monopoly status for its experimental Covid-19 drug
In an unexpected move, Gilead Sciences (GILD) has asked the Food and Drug Administration to…
Ecuador becomes the latest country to eye compulsory licensing for Covid-19 products
As the novel coronavirus continues to spread, Ecuador has become the latest country in which…
STAT Plus: Congress’s coronavirus stimulus package contains plenty of unrelated wins for the health industry
WASHINGTON — A $1 trillion stimulus proposal unveiled Thursday evening by Senate Majority Leader Mitch…
A drug maker recently doubled the price of chloroquine — but in response to the coronavirus pandemic, it’s cutting it in half
WASHINGTON — A company that makes a medication increasingly touted as a promising coronavirus treatment,…
STAT Plus: Preventing other Shkreli-like debacles may not save the government much money
After Martin Shkreli took a 5,000% price hike on a decades-old medicine and thwarted rivals,…
Opinion: Insulin prices and pharmacy benefit manager rebates: pin the tail on the patient
Over the past 15 years, insulin prices have more than doubled. Pharmaceutical companies have been…
Chilean lawmakers support compulsory licensing for coronavirus medicines and vaccines
Concerned about access to treatments for the fast-spreading coronavirus, Chile’s lower house of Congress passed…
STAT Plus: Global spending on drugs may hit $1.1 trillion by 2024, but the rate of growth is forecast to slow
Global spending on prescription medicines is forecast to increase between 2% and 5% annually over…
Opinion: Mending the broken social contract for pharmaceutical pricing and innovation
The biopharmaceutical industry is under unprecedented assault by the public and politicians. Hostility over launch…
STAT Plus: Will Trump’s new plan to cap insulin costs in Medicare actually save seniors much money? It’s complicated
WASHINGTON — The Trump administration claims its newest plan to cap insulin copays could solve…
STAT Plus: Under pressure, Trump administration looks to cap insulin costs with a Medicare program
The Trump administration announced a new voluntary program that would lower the out-of-pocket cost Medicare…
STAT Plus: Drug companies, Canadians, pharmacists and more blast Trump’s drug importation plan
WASHINGTON — The Trump administration is being flooded with opposition to its plan for allowing…
STAT Plus: A recently approved Gilead HIV prevention pill is not cost-effective and should be cut in half, study says
The price of a Gilead Sciences (GILD) pill approved in the U.S. last fall to…
STAT Plus: Oh, Canada! Vertex battles another country over access to cystic fibrosis treatments
A row has broken out between Vertex Pharmaceuticals (VRTX) and Canadian officials over access to…
See one woman’s complicated, costly journey to a Canadian strip mall pharmacy — all for cheaper insulin
Just after Emma Kleck turned 26, she started looking up flights to Canada. Kleck, who…
.jpg)
Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates
A simmering feud between the federal government and Mallinckrodt (MNK) took a new turn as…
STAT Plus: Drug prices rose three times faster than inflation over the past decade, despite discounts
Amid intensifying anger over the rising cost of medicines, a key piece of data has…
STAT Plus: New estimate says developing a drug costs $1.3 billion, which is a lot, but less than companies often say
Estimates of how much it cost to invent and test a new medicine have been…
STAT Plus: Novartis generic unit to pay $195 million to settle price fixing charges
In the latest fallout from a federal probe into generic drug price fixing, the Sandoz…
Azar hits a sour note on pricing for a potential coronavirus vaccine
Let them eat cake. This is effectively what Health and Human Services Secretary Alex Azar…
STAT Plus: Senators threaten to subpoena Express Scripts for failing to produce insulin documents
The ranking members of the Senate Finance Committee are threatening to issue a subpoena to…
STAT Plus: Tracking pharmaceuticals in the supply chain remains difficult due to sloppy paperwork
As Americans debate whether to import prescription drugs from Canada to relieve rising costs, a…
Opinion: Will the newest pill for HIV prevention fuel progress — or profits?
Four decades after the HIV epidemic began, there’s finally hope it might end. Indeed, “Getting…
STAT Plus: An FDA program to ensure decades-old drugs finally get approved is costing billions in price hikes
Back in 2006, the FDA launched an effort to force drug companies to win regulatory…
STAT Plus: ICER, the controversial cost-effectiveness watchdog, reverses course on two migraine drugs
In an unusual move, the Institute for Clinical and Economic Review has reversed course and…
STAT Plus: New partnership tries to make up for missing drug data in cost-effectiveness analyses
The Institute for Clinical and Economic Review, ICER, a nonprofit that has become a central…
STAT Plus: Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence
As out-of-pocket costs rise for medicines used to treat certain neurologic disorders — such as…
STAT Plus: Pharma execs criticize a drug maker over pricing and claim orphan drug law is being misused
Several prominent biotech and pharmaceutical executives are openly criticizing a huge price hike for a…
STAT Plus: Sen. Chuck Grassley takes your questions on drug prices, insulin, and innovation
WASHINGTON — Sen. Chuck Grassley has a clear position on this Congress’s priority list. “You…